These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29071486)

  • 41. A single-center retrospective study on epidemiological and Traditional Chinese Medicine syndrome characteristics of 21010 patients with reflux/heartburn symptoms.
    Yanping T; Peicai LI; Xi L; Lei L; Yanxia G; Xiaodong W; Lina L; Li Y
    J Tradit Chin Med; 2023 Jun; 43(3):574-581. PubMed ID: 37147760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dexlansoprazole is Effective in Relieving Heartburn during the Fasting Month of Ramadan.
    Rimmani HH; Rustom LBO; Rahal MA; Shayto RH; Chaar H; Sharara AI
    Dig Dis; 2019; 37(3):188-193. PubMed ID: 30625462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
    Triadafilopoulos G; Kamal A; Clarke JO
    Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Functional heartburn--update 2013].
    Storr M
    MMW Fortschr Med; 2013 Dec; 155 Suppl 4():100-3. PubMed ID: 24934062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trial.
    Kakushima N; Hori K; Ono H; Horimatsu T; Uedo N; Ohata K; Doyama H; Kaneko K; Oda I; Hikichi T; Kawahara Y; Niimi K; Takaki Y; Mizuno M; Yazumi S; Hosokawa A; Imagawa A; Niimi M; Yoshimura K; Muto M
    J Gastroenterol; 2016 Feb; 51(2):104-11. PubMed ID: 25940151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial.
    Vaezi MF; Fass R; Vakil N; Reasner DS; Mittleman RS; Hall M; Shao JZ; Chen Y; Lane L; Gates AM; Currie MG
    Gastroenterology; 2020 Jun; 158(8):2093-2103. PubMed ID: 32092310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of non-erosive reflux disease and dynamics of the esophageal microbiome: a prospective multicenter study.
    Park CH; Seo SI; Kim JS; Kang SH; Kim BJ; Choi YJ; Byun HJ; Yoon JH; Lee SK
    Sci Rep; 2020 Sep; 10(1):15154. PubMed ID: 32938975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
    Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
    J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised clinical trial: oesophageal radiofrequency energy delivery versus sham for PPI-refractory heartburn.
    Zerbib F; Sacher-Huvelin S; Coron E; Coffin B; Melchior C; Ponchon T; Cholet F; Chabrun E; Vavasseur F; Gorbatchef C; Zalar A; Mion F; Robaszkiewicz M; Le Rhun M; Leroy M; Paul Galmiche J; Bruley des Varannes S
    Aliment Pharmacol Ther; 2020 Aug; 52(4):637-645. PubMed ID: 32656869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastroesophageal reflux disease management according to contemporary international guidelines: a translational study.
    Pace F; Riegler G; de Leone A; Dominici P; Grossi E;
    World J Gastroenterol; 2011 Mar; 17(9):1160-6. PubMed ID: 21448420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    Sigterman KE; van Pinxteren B; Bonis PA; Lau J; Numans ME
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD002095. PubMed ID: 23728637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY
    J Dig Dis; 2012 Dec; 13(12):605-8. PubMed ID: 23134478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.
    Tamura Y; Funaki Y; Izawa S; Iida A; Yamaguchi Y; Adachi K; Ogasawara N; Sasaki M; Kaneko H; Kasugai K
    World J Gastroenterol; 2015 Apr; 21(16):5009-16. PubMed ID: 25945016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.
    Vakil N; Niklasson A; Denison H; Rydén A
    BMC Gastroenterol; 2014 Oct; 14():177. PubMed ID: 25304129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the efficiency of two different proton pump inhibitor formula in treatment of patients with atypical gastroesophageal reflux disease: a prospective randomized study.
    Lin XH; Luo JC; Ting PH; Chang TE; Huang YH; Hou MC; Lee FY
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2096-2102. PubMed ID: 32401385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
    Lee KJ
    Korean J Gastroenterol; 2015 Aug; 66(2):70-4. PubMed ID: 26289239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.